A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder-Reference-Cited by-同舟云学术

A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder

Published:2023-04-01 Issue:3 Volume:33 Page:91-100
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Strawn Jeffrey R.¹²³^ORCID,Moldauer Leslie⁴,Hahn Rebekah D.⁴,Wise Alexandria⁴,Bertzos Kristina⁴,Eisenberg Beth⁴,Greenberg Edward⁵,Liu Chengcheng⁶,Gopalkrishnan Mallika⁶,McVoy Molly⁷⁸^ORCID,Knutson James A.⁹

Affiliation:

1. Department of Psychiatry and Behavioral Neuroscience, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.

2. Anxiety Disorders Research Program, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.

3. Division of Child & Adolescent Psychiatry and Division of Clinical Pharmacology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

4. Syneos Health, Morrisville, North Carolina, USA.

5. AbbVie, Lake Bluff, Illinois, USA.

6. AbbVie, Madison, New Jersey, USA.

7. University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

8. Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

9. Core Clinical Research, Everett, Washington, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2023.0004